Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
MIRM
$93.99
+0.71%
MIRM
· Mirum Pharmaceuticals, Inc.
$93.99
+0.66 (+0.71%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$6.14B
Shares
65.28M
Volume · Nov 13
331.08K
Avg daily vol (3M)
680.13K
All webcasts
Earnings call · FY2024 Q2
Mirum Pharmaceuticals, Inc. (MIRM) Q2 2024 Earnings Call
Revenue
$77.88M
+107.7% YoY
Diluted EPS
-$0.52
Net income
-$24.64M
Forward guidance
1 guided metrics
Management's latest ranges and targets are included below.
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
Forward guidance
From the 8-K filed Aug 7, 2024.
| Metric | Period | Guided | Basis |
|---|---|---|---|
|
Global net product sales
Maintained
full-year 2024
|
$310M – $320M | — |
SEC filing · Item 2.02
8-K earnings release
Filed Aug 7, 2024 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 7, 2024 · complete as-filed document